These data confirm that analyzing Chx10 immunoreactivity alone is not an adequate approach for quantifying total V2a SpINs in NPC grafts; indeed, reporter cell labeling identified a two-to-three-fold increase in V2a SpIN abundance. Here, VSX2 is linked to nasopharyngeal carcinoma.